<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.0.38">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Vascular Surgery Exam Prep - 3&nbsp; Angioaccess</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./thoracic-aorta.html" rel="next">
<link href="./upper-extremity.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-T4DWNE55D1"></script>

<script type="text/javascript">

window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-T4DWNE55D1', { 'anonymize_ip': true});
</script>
<script async="" src="https://hypothes.is/embed.js"></script>


</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
    <div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Angioaccess</span></h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Vascular Surgery Exam Prep</a> 
        <div class="sidebar-tools-main">
    <a href="https://github.com/adam-mdmph/vs-examprep.git" title="Source Code" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
    <a href="https://twitter.com/intent/tweet?url=|url|" title="Twitter" class="sidebar-tool px-1"><i class="bi bi-twitter"></i></a>
</div>
    </div>
      </div>
      <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">Preface</a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./authors.html" class="sidebar-item-text sidebar-link">Authors and Contributors</a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./cerebrovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Cerebrovascular</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./upper-extremity.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Upper Extremity</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./hemodialysis.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Angioaccess</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./thoracic-aorta.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Thoracic Aorta</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./abdominal-aneurysms.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Abdominal Aneurysms</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./lower-extremity.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Lower Extremity</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./renal.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Renal</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./mesenteric.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Mesenteric Disease</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./vascular-trauma.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Vascular Trauma</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./venous-disease.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Venous Disease</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./vascular-lab.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Vascular Lab</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./endovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Endovascular</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">References</a>
  </div>
</li>
    </ul>
    </div>
</nav>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#planning-access-creation" id="toc-planning-access-creation" class="nav-link active" data-scroll-target="#planning-access-creation"> <span class="header-section-number">3.1</span> Planning access creation</a></li>
  <li><a href="#techniques-for-access-creation" id="toc-techniques-for-access-creation" class="nav-link" data-scroll-target="#techniques-for-access-creation"> <span class="header-section-number">3.2</span> Techniques for access creation</a></li>
  <li><a href="#maintenance-and-complications" id="toc-maintenance-and-complications" class="nav-link" data-scroll-target="#maintenance-and-complications"> <span class="header-section-number">3.3</span> Maintenance and complications</a>
  <ul class="collapse">
  <li><a href="#failure-to-mature" id="toc-failure-to-mature" class="nav-link" data-scroll-target="#failure-to-mature"> <span class="header-section-number">3.3.1</span> Failure to mature</a></li>
  <li><a href="#access-failure" id="toc-access-failure" class="nav-link" data-scroll-target="#access-failure"> <span class="header-section-number">3.3.2</span> Access Failure</a></li>
  <li><a href="#sec-steal-syndrome" id="toc-sec-steal-syndrome" class="nav-link" data-scroll-target="#sec-steal-syndrome"> <span class="header-section-number">3.3.3</span> Steal Syndrome</a></li>
  <li><a href="#neuropathy-and-neuropraxia" id="toc-neuropathy-and-neuropraxia" class="nav-link" data-scroll-target="#neuropathy-and-neuropraxia"> <span class="header-section-number">3.3.4</span> Neuropathy and Neuropraxia</a></li>
  <li><a href="#perioperative-neuropraxia" id="toc-perioperative-neuropraxia" class="nav-link" data-scroll-target="#perioperative-neuropraxia"> <span class="header-section-number">3.3.5</span> Perioperative neuropraxia</a></li>
  <li><a href="#bleeding-and-aneurysm" id="toc-bleeding-and-aneurysm" class="nav-link" data-scroll-target="#bleeding-and-aneurysm"> <span class="header-section-number">3.3.6</span> Bleeding and Aneurysm</a></li>
  </ul></li>
  <li><a href="#dialysis-catheters" id="toc-dialysis-catheters" class="nav-link" data-scroll-target="#dialysis-catheters"> <span class="header-section-number">3.4</span> Dialysis Catheters</a></li>
  <li><a href="#peritoneal-dialysis" id="toc-peritoneal-dialysis" class="nav-link" data-scroll-target="#peritoneal-dialysis"> <span class="header-section-number">3.5</span> Peritoneal Dialysis</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title d-none d-lg-block"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Angioaccess</span></h1>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<p><strong>UNDER CONSTRUCTION - This Chapter is Currently in DRAFT mode</strong></p>
<p><strong>28 Mar 2020</strong>: <em>Young Lee, MD and Matthew Smeds, MD</em></p>
<div class="cell">
<div class="cell-output-display">
<audio controls=""> <source src="https://traffic.libsyn.com/audiblebleeding/VSITE_Revew_-_HD_Access_post_auphonic.mp3" type="audio/mpeg"> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
</div>
</div>
<section id="planning-access-creation" class="level2" data-number="3.1">
<h2 data-number="3.1" class="anchored" data-anchor-id="planning-access-creation"><span class="header-section-number">3.1</span> Planning access creation</h2>
<p>Management of Dialysis access is an important topic of discussion, not only because it is a significant part of board examinations, but also because healthcare costs continue to rise for ESRD patients, particularly during the transition from CKD to ESRD. This is attributed to use of dialysis catheters and frequent hospitalizations for arteriovenous access failures and related procedures.</p>
<p>The National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-KDOQI) and SVS has provided guidelines in the follow areas:<span class="citation" data-cites="nationalkidneyfoundation2015 sidawy2008">(<a href="references.html#ref-nationalkidneyfoundation2015" role="doc-biblioref">Foundation 2015</a>; <a href="references.html#ref-sidawy2008" role="doc-biblioref">Sidawy et al. 2008</a>)</span></p>
<ul>
<li><p>Timing of referral to access surgeons</p></li>
<li><p>Operative strategies to maximize placement of autogenous AV accesses</p></li>
<li><p>First choice for autogenous access</p></li>
<li><p>Choice of AV access when a patient is not a suitable candidate for a forearm autogenous access</p></li>
<li><p>The role of monitoring and surveillance of AV access management</p></li>
<li><p>Conversion of a prosthetic AV access to a secondary autogenous AV access</p></li>
<li><p>Management of nonfunctional or failed AV access</p></li>
</ul>
<p><strong>This brings us to the question, who needs dialysis access?</strong></p>
<p>Patients should be referred to a vascular surgeon for access when their creatinine clearance is &lt;25mL/min which is CKD stage 4. You want to provide adequate time for your autogenous access to mature, so the ideal time for access creation would be &gt; 6 months for anticipated need of dialysis. This allows for time for any subsequent interventions if your access is not maturing.</p>
<p><strong>Should prosthetic access also be placed several months before anticipated dialysis?</strong></p>
<p>Prosthetic access patency is limited by duration of access placement, thus, if a patient requires prosthetic access, placement should be delayed until about 3-6 weeks before initiation of dialysis.<span class="citation" data-cites="nationalkidneyfoundation2015">(<a href="references.html#ref-nationalkidneyfoundation2015" role="doc-biblioref">Foundation 2015</a>)</span></p>
<p><strong>For dialysis access creation, which site should be considered and used first?</strong></p>
<p>Due to the easier accessibility and lower infection rates, upper extremity access sites are used first. Furthermore, you want to place your access as far distally in the extremity as possible to preserve the proximal arm for future accesses.</p>
<p><strong>What are some important considerations in a patient’s history when planning a dialysis access?</strong></p>
<p>It is important to find out recent history of:</p>
<ul>
<li><p>Previous access procedures</p></li>
<li><p>Peripheral IV lines</p></li>
<li><p>Sites of any existing or previous indwelling catheters including pacemakers and defibrillators</p></li>
<li><p>Trauma or surgery to the upper extremities</p></li>
</ul>
<p>Moreover, you also want to consider the patient’s quality of life, thus, noting which extremity is dominant is important. If possible, you want to create your dialysis access in the nondominant arm so that when the patient is receiving dialysis multiple times a week, they are able to use their dominant arm during their dialysis sessions.</p>
<p>However, placing a fistula with lowest rate of failure is preferred to using non-dominant hand. Therefore, placement of access on the patients dominant side would be preferred over placement of access with high risk of failure (i.e.&nbsp;on the side of an implantable cardiac device).<span class="citation" data-cites="sgroi2019">(<a href="references.html#ref-sgroi2019" role="doc-biblioref">Sgroi et al. 2019</a>)</span></p>
<p><strong>As with any preoperative planning, physical examination is extremely important. Central venous stenosis can cause problems such as prolonged bleeding after dialysis sessions at the puncture site. What are some signs of central venous stenosis?</strong></p>
<p>Unilateral arm swelling or edema and prominent venous collaterals are signs of central venous stenosis. Central venous stenosis can lead to venous hypertension which affects access patency and function, and also causes disabling edema.</p>
<p>Beyond signs of central venous stenosis, when examining a patient, an Allen’s test should always be performed to evaluate palmer arch patency.</p>
<p><strong>Preoperative planning should also include arterial and venous assessments. What are your size requirements for the artery and the vein to be used in your dialysis access creation?</strong></p>
<p>First, you want equal pressure gradients in bilateral upper extremities. If there is a pressure differential &gt;20mmHg or pulses are non-palpable then patients should undergo a duplex ultrasound to evaluate for arterial insufficiency and and the artery should be greater than or equal to 2mm. Segmental pressures have limited applicability. Patients with correctable lesions on duplex may consider undergoing angiography and intervention to optimize inflow.<span class="citation" data-cites="sidawy2008">(<a href="references.html#ref-sidawy2008" role="doc-biblioref">Sidawy et al. 2008</a>)</span></p>
<p>A venous duplex should also be done to evaluate for diameter, distensibility and continuity. A vein mapping is useful to determine the size of the patient’s superficial veins at various points in the forearm and upper arm. The vein should ideally be at least 3mm, but 2.5mm will likely dilate after regional anesthesia and be sufficient for access.<span class="citation" data-cites="huber2002 smith2012">(<a href="references.html#ref-huber2002" role="doc-biblioref">Huber et al. 2002</a>; <a href="references.html#ref-smith2012" role="doc-biblioref">Smith, Gohil, and Chetter 2012</a>)</span></p>
<p><strong>Autogenous access should always be considered first due to higher patency rates, lower infection rates, and longer duration of access survival. What are the different configurations of autogenous accesses?</strong></p>
<p>The first and best option would be direct arteriovenous anastomosis. However, if that is not possible, then venous transposition should be considered next follow by venous translocation.</p>
<p>Venous transposition is for deeper veins such as the basilic vein, which is transposed so the vein lies just below the skin for easier access for puncture during dialysis sessions. Transpositions are generally a 2-stage procedure in which the direct arteriovenous anastomosis is created during the first stage and once the vein has arterialized 4-6 weeks later, the second stage of transposition is done when the vein is easier to mobilize. Translocation procedures include harvesting the femoral or saphenous vein and using it as a conduit for AV access creation in the upper extremity.</p>
<p><strong>When can a venous transposition be done in a one stage procedure?</strong></p>
<p>When the vein is &gt;4mm. When a patient has not been initiated on dialysis and there is marginal vein that would require transposition, but carry a significant risk of graft failure then a first-stage BB fistula may be appropriate.</p>
<p>When comparing single- to two-stage brachiobasilic fistula, two-stage creation had high rates of primary patency at 2-years. However, there was no difference in infection rate, steal syndrome, hematoma, pseudoaneurysm, stenosis, failure rate, primary or secondary patency at 1-year or secondary patency at 2-years.<span class="citation" data-cites="junyanwee2018">(<a href="references.html#ref-junyanwee2018" role="doc-biblioref">Jun Yan Wee et al. 2018</a>)</span></p>
<p><strong>It was mentioned earlier that the dialysis access should be created as distally as possible on the extremity. What are some of the most distal locations?</strong></p>
<p>The snuffbox fistula, which is the posterior radial branch to cephalic direct access and Brescia-Cimino-Appel (often shortened to just Cimino) fistula which is the radial-cephalic wrist direct access are two of the most distal fistulas that can be created. Overall, these have comparable patency and ischemia risk. While snuff box fistulas carry a 10% failure rate at 1mo, the majority are able to be converted to RC fistulas.<span class="citation" data-cites="siracuse2019">(<a href="references.html#ref-siracuse2019" role="doc-biblioref">Siracuse et al. 2019</a>)</span></p>
<p><strong>What are your arterial and venous options in the upper extremity?</strong></p>
<p>In the forearm, you have your radial, ulnar, and brachial arteries and cephalic and basilic veins. In the upper arm, you have your brachial or proximal radial arteries and cephalic, basilic, brachial and axillary veins.</p>
<p>If adequate vein is available, most common access sites distal to proximal include:</p>
<ol type="1">
<li><p>Snuff box</p></li>
<li><p>Radiocephalic</p></li>
<li><p>Basilic transposition in forearm</p></li>
<li><p>Brachiocephalic fistula - these have a few advantages over more distal fistulas, including higher maturation rates, decreased time to maturity, higher patency and functional primary patency.<span class="citation" data-cites="nguyen2007">(<a href="references.html#ref-nguyen2007" role="doc-biblioref">Nguyen et al. 2007</a>)</span></p></li>
<li><p>Brachiobasilic fistula<span class="citation" data-cites="gilmore2006">(<a href="references.html#ref-gilmore2006" role="doc-biblioref">Gilmore 2006</a>)</span></p></li>
<li><p>Vein transposition from a remote site - Femoral vein transposition can be used for upper extremity dialysis access in patients with previous upper extremity access complicated by infection, thus not a candidate for prosthetic, but no central stenosis. There is a high rate of hand ischemia due to larger conduit (up to 43%).<span class="citation" data-cites="huber2004">(<a href="references.html#ref-huber2004" role="doc-biblioref">Huber et al. 2004</a>)</span></p></li>
</ol>
<p><strong>If you need to use a prosthetic graft, what would you use?</strong></p>
<p>PTFE is the most common, they make tapered 4-7mm grafts to ensure the size of your arterial anastomosis isn’t too large to minimize chances of steal. However, recent publications found that there is no difference between tapered and non-tapered grafts in terms of primary patency, steal syndrome, complication rates or need for reintervention.<span class="citation" data-cites="roberts2019 han2017">(<a href="references.html#ref-roberts2019" role="doc-biblioref">Roberts et al. 2019</a>; <a href="references.html#ref-han2017" role="doc-biblioref">Han, Seo, and Ryu 2017</a>)</span></p>
<p>Overall AVG have benefit of earlier cannulation, discussed later, however they have lower patency rates and higher infection rates. There is no difference between grafts and fistulas for perioperative morbidity and mortality.<span class="citation" data-cites="macsata2019">(<a href="references.html#ref-macsata2019" role="doc-biblioref">Macsata and Sidawy 2019</a>)</span></p>
<p><strong>For patients with central venous stenosis or occlusion, what is another alternative upper extremity access creation?</strong></p>
<p>Two overall strategies for managing patients with severe central venous stenosis or occlusion are lower extremity AV access of hybrid catheter/grafts. Patency of femoral vein transposition is better than hybrid catheter/graft placement.<span class="citation" data-cites="brownie2016 glickman2011">(<a href="references.html#ref-brownie2016" role="doc-biblioref">Brownie 2016</a>; <a href="references.html#ref-glickman2011" role="doc-biblioref">Glickman 2011</a>)</span> We will cover specifics of these techniques later.</p>
<p>For lower extremity AV access, femoral vein transposition has been shown to have the best outcomes, followed by saphenous vein transposition and graft placement. Lower extremity access should be avoided in patients with peripheral vascular disease or lower extremity ischemic symptoms–when in doubt perform duplex and segmental pressures to fully evaluate. Veins should also be evaluated to ensure patency more proximally.<span class="citation" data-cites="parekh2016">(<a href="references.html#ref-parekh2016" role="doc-biblioref">Parekh, Niyyar, and Vachharajani 2016</a>)</span></p>
<p>For patients where lower extremity access may not be appropriate, the hemodialysis reliable outflow (HeRO) device can come to the rescue. These devices may not have been encountered in your training, so we will go into detail here. This device is composed of 2 components: a graft which is made of 6mm PTFE with a titanium coupler at one end, and a venous outflow component of a 19 Fr silicone catheter reinforced with a nitinol braid to prevent kinking. The graft portion is anastomosed to an artery, usually brachial, and is tunneled subcutaneously and the venous component is percutaneously placed into the right atrium via the IJ or subclavian vein. The two components are connected with a titanium coupler at the deltopectoral groove. If you need more immediate dialysis, the super HeRO comes to the rescue in which the graft portion is the early cannulation graft.</p>
<p>Hybrid catheter/grafts are good alternatives in patients with previous line infections, central stenosis, peripheral vascular disease and no suitable vein in the upper extremities. They have shown fewer bacteremia episodes than catheter, low primary patency rate and acceptable secondary patency rates.<span class="citation" data-cites="alshakarchi2015">(<a href="references.html#ref-alshakarchi2015" role="doc-biblioref">J. Al Shakarchi et al. 2015</a>)</span> Absolute contraindications include donor artery &lt;3mm, inability to dilate outflow vein to 19f, allergy to device materials (ePTFE, silicone, titanium, nitinol), and current active infection.<span class="citation" data-cites="meritmedical">(<a href="references.html#ref-meritmedical" role="doc-biblioref">Medical, n.d.</a>)</span></p>
</section>
<section id="techniques-for-access-creation" class="level2" data-number="3.2">
<h2 data-number="3.2" class="anchored" data-anchor-id="techniques-for-access-creation"><span class="header-section-number">3.2</span> Techniques for access creation</h2>
<p><strong>The techniques of arteriovenous fistula creation are common across access sites. Can you go through the techniques?</strong></p>
<p>First the vein is identified and the distal end is transected and flushed with heparin. By flushing with the heparin, you are able to access the caliber and extent of the vein as well as identify any side branches</p>
<p>Then after distal and proximal control of your artery, a 4-6mm arteriotomy is made. The length is limited to decrease incidence of arterial steal. The artery is then flushed with heparin to avoid thrombosis during the anastomosis and an anastomosis is created between the side of the artery and the end of the vein. A 6-0 or 7-0 nonabsorbable continuous suture should be used to create the anastomosis to avoid future dilation of the anastomosis.</p>
<p><strong>What are some other options if an access is not able to be created in the upper extremity?</strong></p>
<p>Autogenous accesses can also be created in the lower extremity. Femoral artery to femoral vein or saphenous vein anastomosis can be created. Both veins have to be transposed. Synthetic grafts have high infection rates (as high as 22% in some series) and only a 50% patency at 6 months.<span class="citation" data-cites="antoniou2009 lazarides2018 pike2019">(<a href="references.html#ref-antoniou2009" role="doc-biblioref">Antoniou et al. 2009</a>; <a href="references.html#ref-lazarides2018" role="doc-biblioref">Lazarides et al. 2018</a>; <a href="references.html#ref-pike2019" role="doc-biblioref">Pike et al. 2019</a>)</span> Risk of lower extremity ischemia increased with burden of PVD, AV fistula vs graft, distal arterial inflow, and large femoral vein mismatch, but can be tempered by banding/narrowing of femoral vein at the time of surgery.<span class="citation" data-cites="antoniou2009 bourquelot2012 gradman2005">(<a href="references.html#ref-antoniou2009" role="doc-biblioref">Antoniou et al. 2009</a>; <a href="references.html#ref-bourquelot2012" role="doc-biblioref">Bourquelot et al. 2012</a>; <a href="references.html#ref-gradman2005" role="doc-biblioref">Gradman, Laub, and Cohen 2005</a>)</span></p>
<p>Access creation in the chest wall or cervical region is also possible with axillary artery to ipsilateral axillary vein loop access, axillary artery to contralateral axillary or jugular vein straight access (ie necklace access) and brachial artery to jugular vein straight access. Keep in mind that for these fistulas, the central veins must be patent.</p>
<p><strong>Are there benefits to different anesthetic techniques used during access placement, such as regional anesthesia?</strong></p>
<p>Regional anesthesia for AVF creation has been associated with higher perioerative flow and lower rates of vasospasm resulting in higher rates of short term patency. Regional anesthesia has not been associated with perioperative rates of major morbidity or mortality.<span class="citation" data-cites="aitken2016 siracuse2014">(<a href="references.html#ref-aitken2016" role="doc-biblioref">Aitken et al. 2016</a>; <a href="references.html#ref-siracuse2014" role="doc-biblioref">Siracuse et al. 2014</a>)</span></p>
<p><strong>What is the role for endovascular creation of AV fistula?</strong></p>
<p>New methods are now available to perform an upper extremity AVF endovascularly, although many patients would be suitable candidates, as of now the usability of these fistulas have not matched that of surgically placed AVF.<span class="citation" data-cites="lok2017">(<a href="references.html#ref-lok2017" role="doc-biblioref">Lok et al. 2017</a>)</span></p>
<p><strong>When is the newly created dialysis access ready for use?</strong></p>
<p>A good way to remember this is the rule of 6’s. it’s ready to use when the Fistula is 6mm in Diameter, has a flow of 600ml/min, is 6mm from the surface of the skin and usually takes 6 weeks to mature.</p>
<p>Prosthetic AV accesses can be used as early as 2 weeks postoperatively. If you use the 3-layer early cannulation grafts, the access can be used as early as 24 hours after access creation. This is great because it offers the potential for avoidance of dialysis catheters in patients who need dialysis immediately.<span class="citation" data-cites="glickman2015">(<a href="references.html#ref-glickman2015" role="doc-biblioref">Glickman et al. 2015</a>)</span></p>
</section>
<section id="maintenance-and-complications" class="level2" data-number="3.3">
<h2 data-number="3.3" class="anchored" data-anchor-id="maintenance-and-complications"><span class="header-section-number">3.3</span> Maintenance and complications</h2>
<section id="failure-to-mature" class="level3" data-number="3.3.1">
<h3 data-number="3.3.1" class="anchored" data-anchor-id="failure-to-mature"><span class="header-section-number">3.3.1</span> Failure to mature</h3>
<p><strong>What are some reasons why an access may fail to mature?</strong></p>
<p>Sometimes your access may have arterial inflow stenosis. This is difficult to detect clinically because there will be a palpable thrill, however, due to the stenosis, the flow is not sufficient enough for dialysis. In the absence of arterial inflow issues, collateral or large venous branches can divert blood away from the main access channel resulting in insufficient flow.</p>
<p><strong>If the newly created AV fistula is not maturing, what are some secondary procedures to help with maturation?</strong></p>
<p>Open procedures include vein patches, interposition vein grafts, vein transposition to proximal arteries, branch ligations, and vein superficialization. Endovascular procedures include arterial and venous angioplasties to improve inflow or outflow issues.<span class="citation" data-cites="sidawy2008">(<a href="references.html#ref-sidawy2008" role="doc-biblioref">Sidawy et al. 2008</a>)</span></p>
</section>
<section id="access-failure" class="level3" data-number="3.3.2">
<h3 data-number="3.3.2" class="anchored" data-anchor-id="access-failure"><span class="header-section-number">3.3.2</span> Access Failure</h3>
<p><strong>Once a dialysis access is created, maintenance of the access is extremely important. The flow disturbances and hemodynamic changes associated with AV access creation causes intimal hyperplasia leading to venous outflow stenosis. This can ultimately lead to access thrombosis and failure. What are some methods of detecting access failure?</strong></p>
<p>One way of detecting a well functioning access is a strong thrill at the arterial anastomosis which continues a few centimeters into the outflow vein. If you feel a pulsation near the venous outflow, then a stenosis or thrombosis is likely. If you feel a thrill distal to the area of pulsation, then you have likely localized your area of stenosis. It is important to note that you may feel a pulsation at a pseudoaneurysm independent of venous outflow issues.</p>
<p>Other signs of outflow stenosis are collateral veins or upper extremity edema.<span class="citation" data-cites="padberg2008">(<a href="references.html#ref-padberg2008" role="doc-biblioref">Padberg, Calligaro, and Sidawy 2008</a>)</span> This is indicative of venous hypertension likely secondary to stenosis. You will typically see this in the shoulder area or anterior chest as a results of subclavian vein stenosis/thrombosis. Moreover, these high venous pressures as a result of the stenosis can result in excessive and prolonged bleeding after removal of needles from the dialysis puncture sites. This is often the first sign of elevated venous pressures. These patients should undergo a fistulogram to evaluate for underlying outflow stenosis.<span class="citation" data-cites="caromonroig2018">(<a href="references.html#ref-caromonroig2018" role="doc-biblioref">Caro Monroig et al. 2018</a>)</span></p>
<p>The most common cause of graft failure in upper extremity fistulas is venous outflow stenosis and in grafts is venous anastomotic intimal hyperplasia.<span class="citation" data-cites="berman2001 padberg2008">(<a href="references.html#ref-berman2001" role="doc-biblioref">Berman and Gentile 2001</a>; <a href="references.html#ref-padberg2008" role="doc-biblioref">Padberg, Calligaro, and Sidawy 2008</a>)</span> Diagnostic fistulogram is a very useful tool to diagnose and treat potential access complications. Diagnostic fistulogram is often performed with proximal access of the fistula a few centimeters distal to the anastomosis. Compression of venous outflow is necessary to evaluate for inflow and anastomotic issues.<span class="citation" data-cites="bountouris2018">(<a href="references.html#ref-bountouris2018" role="doc-biblioref">Bountouris et al. 2018</a>)</span></p>
<p>Finally, even patients with normal physical exam can have issues while on the hemodialysis circuit, such as recirculation. When in doubt, if there are recurrent issues with hemodialysis, the patient should undergo a fistulogram to evaluate for occult venous outflow stenosis that may be missed on other diagnostic modalities.<span class="citation" data-cites="sidawy2008">(<a href="references.html#ref-sidawy2008" role="doc-biblioref">Sidawy et al. 2008</a>)</span></p>
<p><strong>What are some endovascular interventions for a failing access?</strong></p>
<p>First line therapy for outflow stenosis is a simple balloon angioplasty of the stenosed area.<span class="citation" data-cites="berman2001">(<a href="references.html#ref-berman2001" role="doc-biblioref">Berman and Gentile 2001</a>)</span> Insufflation times are generally up to 2-3 minutes. Treatment of stenosis 2/2 intimal hyperplasia often require high pressures of 20 ATM or more. However, this is a double edge sword because this can lead to trauma in the veins stimulating a further intimal hyperplasia process. Some advocate a cutting balloon before high pressure dilation. Stenting is also an option to treat residual stenosis or dissections after balloon angioplasty. Covered stents have shown good patency results.</p>
<p>Some unique situations include, recurrent cephalic arch stenosis which may be best treated with bare metal stenting.<span class="citation" data-cites="shemesh2008">(<a href="references.html#ref-shemesh2008" role="doc-biblioref">Shemesh et al. 2008</a>)</span> Proximal occlusions (i.e.&nbsp;subclavian) may be best treated primarily with a covered stent.<span class="citation" data-cites="agarwal2015 anaya-ayala2011">(<a href="references.html#ref-agarwal2015" role="doc-biblioref">Agarwal 2015</a>; <a href="references.html#ref-anaya-ayala2011" role="doc-biblioref">Anaya-Ayala et al. 2011</a>)</span></p>
<p><strong>If endovascular interventions fail, what are some open options for managing a failing access?</strong></p>
<p>Generally an interposition graft or patch angioplasty is performed and the results of the two techniques are largely equivalent.</p>
<p><strong>If an AV access has ultimately failed and thrombosed, what are your endovascular options at this point?</strong></p>
<p>Some endovascular options are catheter directed thrombolysis with about 2-4mg of tPA injected into the clot, followed by balloon angioplasty (typically an 8mm by 8cm high pressure balloon). A mechanical thrombectomy device, such as angiojet, can also be used in combination to thrombolysis.</p>
<p>Alternatively, an open thrombectomy with a thromboembolectomy balloon and patch angioplasty of venous stenosis areas can also be used. Moreover, a hybrid approach of open thrombectomy with percutaneous interventions of venous stenosis areas has been described.</p>
<p>Immediate postoperative thrombosis of an AV graft is likely technical - inadequate inflow (i.e.&nbsp;small brachial artery) or outflow stenosis/occlusion. Open revision and thrombectomy is often the best option.<span class="citation" data-cites="paulson2002">(<a href="references.html#ref-paulson2002" role="doc-biblioref">Paulson, Ram, and Zibari 2002</a>)</span></p>
<p><strong>What are some ways to manage failing AV access in the setting of ipsilateral vTOS?</strong></p>
<p>Performing a first rib resection in a hemodialysis patient is high risk and controversial. However, if there is a prominent external jugular vein, then there are reports of external to internal jugular vein transposition offering more in line drainage and access salvage.<span class="citation" data-cites="degiovanni2020">(<a href="references.html#ref-degiovanni2020" role="doc-biblioref">DeGiovanni, Son, and Salehi 2020</a>)</span></p>
</section>
<section id="sec-steal-syndrome" class="level3" data-number="3.3.3">
<h3 data-number="3.3.3" class="anchored" data-anchor-id="sec-steal-syndrome"><span class="header-section-number">3.3.3</span> Steal Syndrome</h3>
<p><strong>Earlier, you mentioned steal syndrome, can you explain to us what this is?</strong></p>
<p>Steal syndrome is also known as Access Related Hand Ischemis = ARHI. It is an uncommon but devastating complication of access creation. All patients with arteriovenous fistulas have some degree of physiologic steal or reversal of flow in part of the artery distal to the fistula. However, this is not sufficient enough to cause ischemia. Rather, ischemia results from inadequate collateral circulation and inability of peripheral arteries to meet the increased demand. Diseased vessels do not dilate and stenosis of arteries leads to decreased distal perfusion pressure. Furthermore, hypotension during dialysis further decreases perfusion causing symptoms. Steal can be limb threatening and is graded as follows:</p>
<ul>
<li><p>Grade 0 - asymptomatic, no flow augmentation or steal</p></li>
<li><p>Grade 1 - asymptomatic, mild ischemia with signs of cool extremity and flow augmentation with access occlusion (May be seen in over half of AV access patients)<span class="citation" data-cites="leake2015">(<a href="references.html#ref-leake2015" role="doc-biblioref">Leake et al. 2015</a>)</span></p></li>
<li><p>Grade 2 - moderate/intermittent ischemia that is experienced only during dialysis and patients feel claudication.</p></li>
<li><p>Grade 3 - severe, ischemic pain at rest with tissue loss.</p></li>
</ul>
<p><strong>What are some symptoms and signs of Steal syndrome?</strong></p>
<p>Symptoms include coolness, parasthesias, rest pain, and weakness. Signs of steal include cool to touch, pallor, cyanosis, delayed capillary refill, absent pulses/signals, diminished sensation, weak grip, and in severe cases ulceration or gangrene. If the patient shows improvement with access compression, diagnosis is confirmed.</p>
<p>Patients with acute pain and loss of pulses after AVF creation should first have arterial injury/thrombosis ruled out, but then after diagnosis of steal syndrome should undergo fistula ligation.<span class="citation" data-cites="schanzer2004 yevzlin2016">(<a href="references.html#ref-schanzer2004" role="doc-biblioref">Schanzer and Eisenberg 2004</a>; <a href="references.html#ref-yevzlin2016" role="doc-biblioref">Yevzlin, Chan, and Asif 2016</a>)</span></p>
<p><strong>When is an intervention necessary to treat steal syndrome?</strong></p>
<p>You do not need to intervene for grade 0 and 1.<span class="citation" data-cites="leake2015">(<a href="references.html#ref-leake2015" role="doc-biblioref">Leake et al. 2015</a>)</span> For grade 3 an intervention is mandatory. The goal of treatment includes symptom resolution and access preservation, and this is achieved by reducing access flow and increasing distal arterial flow.</p>
<p>The most important finding on duplex ultrasound to evaluate for steal syndrome is fistula flow rate. High flow rates suggest a primary problem with the fistula, low or normal flow suggests underlying PVD and inflow insufficiency as etiology.<span class="citation" data-cites="alshakarchi2016 leake2015">(<a href="references.html#ref-alshakarchi2016" role="doc-biblioref">Julien Al Shakarchi et al. 2016</a>; <a href="references.html#ref-leake2015" role="doc-biblioref">Leake et al. 2015</a>)</span> Approximately 5% of steal is secondary to inflow stenosis.</p>
<p><strong>What are your intervention options for resolving steal syndrome?</strong></p>
<p>There are multiple ways to manage steal syndrome, detailed as follows:<span class="citation" data-cites="leake2015 gupta2011">(<a href="references.html#ref-leake2015" role="doc-biblioref">Leake et al. 2015</a>; <a href="references.html#ref-gupta2011" role="doc-biblioref">Gupta et al. 2011</a>)</span></p>
<ul>
<li><p>AV Fistula Banding is a simple option to reduce access flow. This is done by suture plication, placement of single narrowing tie or wrap by constrictive cuff to cause a stenosis in the AV access near the arterial anastomosis. A minimally invasive approach is used by the MILLER banding which uses an endoluminal 4 or 5mm balloon as a sizer and a suture is placed around the access with the balloon inflated. This procedure increases arterial inflow towards the hand. Flow should be maintained at 600ml/min.</p></li>
<li><p>Revision using distal inflow (RUDI) involves ligation of the fistula at the arterial anastomosis and reestablishment of flow via a more distal artery by bypass or vein translocation. This allows for decreased flow through the access by reducing the fistula diameter and by taking inflow form a smaller vessel. However, ultimately, the fistula is placed at risk</p></li>
<li><p>Proximalizaiton of arterial inflow (PAI) involves ligation of AV anastomosis, and the inflow is moved to a more proximal level with a prosthetic interposition. Dialysis can be continue via the vein. The main advantage is the native artery’s continuity.<span class="citation" data-cites="zanow2006">(<a href="references.html#ref-zanow2006" role="doc-biblioref">Zanow, Kruger, and Scholz 2006</a>)</span></p></li>
<li><p>Distal revascularization-interval ligation (DRIL) is ultimately considered the best option by many vascular surgeons due to the excellent results shown. There is an arterial bypass created originating proximal to the access and ending distal to the access, with ligation of the artery distal to the anastomosis. This prevents retrograde flow from distal vessels and allows for a low resistance pathway for arterial supply to the hand. DRIL may be particularly useful in patients with distal brachial, proximal ulnar/radial disease, as this can bypass the underlying stenosis as well.<span class="citation" data-cites="leake2015">(<a href="references.html#ref-leake2015" role="doc-biblioref">Leake et al. 2015</a>)</span></p></li>
<li><p>Distal radial artery ligation (DRAL) can be performed for palmar arch steal syndrome from radio-cephalic av accesses, to prevent reversal of flow in the palmar arch. However, the ulnar artery patency needs to evaluated first.</p></li>
</ul>
</section>
<section id="neuropathy-and-neuropraxia" class="level3" data-number="3.3.4">
<h3 data-number="3.3.4" class="anchored" data-anchor-id="neuropathy-and-neuropraxia"><span class="header-section-number">3.3.4</span> Neuropathy and Neuropraxia</h3>
<p><strong>What complication often presents like steal syndrome, but with easily palpable distal pulses?</strong></p>
<p>Access creation can result in neuropathy. It is important to note that over 2/3s of the patients have preexisting peripheral neuropathy. Neuropathy is also graded:</p>
<ul>
<li><p>Grade 0 - asymptomatic</p></li>
<li><p>Grade 1 - mild intermittent changes (pain, paresthesia, numbness with sensory deficit)</p></li>
<li><p>Grade 2 - moderate persistent sensory changes</p></li>
<li><p>Grade 3 - severe sensory changes with progressive motor loss (motion, strength, muscle wasting).</p></li>
</ul>
<p>Ischemic monomelic neuropathy is rare but occurs acutely after AV access creation. Within hours of surgery, patients develop acute pain, weakness, or paralysis of hand and forearm muscles with prominent sensory loss. However, the hand is warm with palpable pulse or audible signal in distal radial and ulnar arteries. It is important to note that pain out of proportion is what differentiates IMN from ARHI. Treatment is access ligation or emergent augmentation of flow.</p>
</section>
<section id="perioperative-neuropraxia" class="level3" data-number="3.3.5">
<h3 data-number="3.3.5" class="anchored" data-anchor-id="perioperative-neuropraxia"><span class="header-section-number">3.3.5</span> Perioperative neuropraxia</h3>
<p><strong>What are some common technical complications after placement of AV access?</strong></p>
<p>Post operative numbness of the thumb, index and middle finger and weakness of abduction and grip strength may suggest median nerve neuropraxia and will likely resolve. However, you need to rule out steal syndrome.<span class="citation" data-cites="talebi2011 vahdatpour2012">(<a href="references.html#ref-talebi2011" role="doc-biblioref">Talebi et al. 2011</a>; <a href="references.html#ref-vahdatpour2012" role="doc-biblioref">Vahdatpour et al. 2012</a>)</span></p>
<p>Postoperative hematoma can often just be observed. However, signs of median nerve compression mandate immediate operative brachial sheath evacuation or the neurologic deficits may become permanent.<span class="citation" data-cites="padberg2008">(<a href="references.html#ref-padberg2008" role="doc-biblioref">Padberg, Calligaro, and Sidawy 2008</a>)</span></p>
<p>Prosthetic grafts can results in seroma from ultrafiltration of the graft and most resolve without intervention.</p>
</section>
<section id="bleeding-and-aneurysm" class="level3" data-number="3.3.6">
<h3 data-number="3.3.6" class="anchored" data-anchor-id="bleeding-and-aneurysm"><span class="header-section-number">3.3.6</span> Bleeding and Aneurysm</h3>
<p><strong>What presentations require urgent revision?</strong></p>
<p>Fistulas that present with bleeding from a visible ulcer, wet scabbing, frank infection or acute pseudoaneurysm often require urgent open revision. Some access may be salvaged, but in acute presentations with significant risk of life threatening hemorrhage the safest option may be to ligate the access and place a temporary dialysis access line.<span class="citation" data-cites="galbusera2009">(<a href="references.html#ref-galbusera2009" role="doc-biblioref">Galbusera, Remuzzi, and Boccardo 2009</a>)</span></p>
<p><strong>Many fistulas develop aneurysms over time. When do fistula aneurysms require revision?</strong></p>
<ul>
<li><p>Pseudoaneurysms often result from trauma due to repeated punctures or poor technique</p></li>
<li><p>True aneurysms result from long standing hemodynamically significant outflow stenosis.</p></li>
</ul>
<p>Both can lead to cannulation difficulties, increased risk of thrombosis, pain, bleeding and cosmetic deformities. AV aneurysms should be revised if they develop skin thinning, ulceration or bleeding. Early skin changes can be observed. Intervention often requires revision with open plication/excision or ligation. When isolated to a short segment, attempts should be made to salvage the fistula.<span class="citation" data-cites="al-jaishi2017 al-thani2017 pasklinsky2011">(<a href="references.html#ref-al-jaishi2017" role="doc-biblioref">Al-Jaishi et al. 2017</a>; <a href="references.html#ref-al-thani2017" role="doc-biblioref">Al-Thani et al. 2017</a>; <a href="references.html#ref-pasklinsky2011" role="doc-biblioref">Pasklinsky et al. 2011</a>)</span></p>
</section>
</section>
<section id="dialysis-catheters" class="level2" data-number="3.4">
<h2 data-number="3.4" class="anchored" data-anchor-id="dialysis-catheters"><span class="header-section-number">3.4</span> Dialysis Catheters</h2>
<p><strong>While ideally every patient would have surgically placed access, many patients still receive dialysis through catheters. What is the difference between an acute and chronic hemodialysis catheter?</strong></p>
<p>Chronic catheters have a subcutaneous cuff at the exit site and tunneled to the vein. This decreases infection rates and makes them less likely to become dislodged. Tunneled hemodialysis catheters can be used up to 12 months.</p>
<p><strong>If catheters cause so much problems such as infection and central venous stenosis, what would be an indication for them?</strong></p>
<p>The most common indication would be for urgent hemodialysis. But other indications include patient who are not operative candidates due to advanced comorbidities, or patients who are unable to have an AVF or AVG due to anatomic feasibility. Temporary dialysis access may also be needed in patients who have just had a peritoneal dialysis catheter placement or in chronic peritoneal dialysis catheter patients requiring abdominal or inguinal surgery.</p>
<p><strong>Which site is the most ideal site for a hemodialysis catheter?</strong></p>
<p>The right internal jugular vein is preferred because it has the best patency.</p>
<p>If all traditional access sites are inaccessible, translumbar IVC catheters may be used as a last resort as salvage. Overall complications are similar to other permanent dialysis access sites, however obesity is a relative contraindication due to potential migration into the soft tissues.</p>
<p><strong>Every procedure has potential complications. What are the immediate complications of catheter placement?</strong></p>
<p>When placed in the internal jugular veins, there is always a chance of a pneumothorax or hemothorax. Wire embolism can occur is control of the wire is lost during the procedure. If the guidewire is placed too far, then there is always a chance of arrhythmia. Thus, the best place for the wire is through the IVC. With a left internal jugular vein approach, there is always a risk of thoracic duct laceration. If a leak is apparent, then the catheter needs to be removed immediately and a pressure dressing applied.</p>
<p><strong>How do you manage infected hemodialysis lines?</strong></p>
<p>Infected hemodialysis lines should be removed. Ideally you should avoid replacing any lines until blood cultures have been negative for 48hrs, particularly subsequent permanent lines<span class="citation" data-cites="vascularaccess2006workgroup2006">(<a href="references.html#ref-vascularaccess2006workgroup2006" role="doc-biblioref">Group 2006</a>)</span></p>
</section>
<section id="peritoneal-dialysis" class="level2" data-number="3.5">
<h2 data-number="3.5" class="anchored" data-anchor-id="peritoneal-dialysis"><span class="header-section-number">3.5</span> Peritoneal Dialysis</h2>
<p><strong>Although not often managed by the vascular surgeon, we should still be aware of another method of dialysis in renal failure patients. What are the indications for peritoneal dialysis?</strong></p>
<p>Peritoneal dialysis is better tolerated and less disruptive to daily life, so is often a better option for young, active patients with less comorbidities. PD can be considered first-line or in patients who are not candidates for HD, but require high patient engagement and education and so may not be appropriate for patients with other chronic diseases limiting independence, unstable housing, cognitive decline or poor management other medical issues.<span class="citation" data-cites="ansari2011">(<a href="references.html#ref-ansari2011" role="doc-biblioref">Ansari 2011</a>)</span></p>
<p>From a technical standpoint, PD may be difficult in patients who have had multiple previous open abdominal surgeries, but can be tolerated in patients who have had minimally invasive or minor abdominal procedures.<span class="citation" data-cites="sinnakirouchenan2011">(<a href="references.html#ref-sinnakirouchenan2011" role="doc-biblioref">Sinnakirouchenan and Holley 2011</a>)</span> Long dwell times with glucose solution can sometimes lead to hyperglycemia. The major reason for conversion from PD to HD is PD catheter infection.<span class="citation" data-cites="li2017">(<a href="references.html#ref-li2017" role="doc-biblioref">Li et al. 2017</a>)</span></p>


<div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography" style="display: none">
<div id="ref-agarwal2015" class="csl-entry" role="doc-biblioentry">
Agarwal, Anil K. 2015. <span>“Endovascular Interventions for Central Vein Stenosis.”</span> <em>Kidney Research and Clinical Practice</em> 34 (4): 228–32. <a href="https://doi.org/10.1016/j.krcp.2015.10.005">https://doi.org/10.1016/j.krcp.2015.10.005</a>.
</div>
<div id="ref-aitken2016" class="csl-entry" role="doc-biblioentry">
Aitken, Emma, Andrew Jackson, Rachel Kearns, Mark Steven, John Kinsella, Marc Clancy, and Alan Macfarlane. 2016. <span>“Effect of Regional Versus Local Anaesthesia on Outcome After Arteriovenous Fistula Creation: A Randomised Controlled Trial.”</span> <em>Lancet (London, England)</em> 388 (10049): 1067–74. <a href="https://doi.org/10.1016/S0140-6736(16)30948-5">https://doi.org/10.1016/S0140-6736(16)30948-5</a>.
</div>
<div id="ref-alshakarchi2015" class="csl-entry" role="doc-biblioentry">
Al Shakarchi, J., J. G. Houston, R. G. Jones, and N. Inston. 2015. <span>“A Review on the Hemodialysis Reliable Outflow (HeRO) Graft for Haemodialysis Vascular Access.”</span> <em>European Journal of Vascular and Endovascular Surgery</em> 50 (1): 108–13. <a href="https://doi.org/10.1016/j.ejvs.2015.03.059">https://doi.org/10.1016/j.ejvs.2015.03.059</a>.
</div>
<div id="ref-alshakarchi2016" class="csl-entry" role="doc-biblioentry">
Al Shakarchi, Julien, Jan Stolba, J. Graeme Houston, and Nicholas Inston. 2016. <span>“Surgical Techniques for Haemodialysis Access-Induced Distal Ischaemia.”</span> <em>The Journal of Vascular Access</em> 17 (1): 40–46. <a href="https://doi.org/10.5301/jva.5000467">https://doi.org/10.5301/jva.5000467</a>.
</div>
<div id="ref-al-jaishi2017" class="csl-entry" role="doc-biblioentry">
Al-Jaishi, Ahmed A., Aiden R. Liu, Charmaine E. Lok, Joyce C. Zhang, and Louise M. Moist. 2017. <span>“Complications of the Arteriovenous Fistula: A Systematic Review.”</span> <em>Journal of the American Society of Nephrology : JASN</em> 28 (6): 1839–50. <a href="https://doi.org/10.1681/ASN.2016040412">https://doi.org/10.1681/ASN.2016040412</a>.
</div>
<div id="ref-al-thani2017" class="csl-entry" role="doc-biblioentry">
Al-Thani, Hassan, Ayman El-Menyar, Noora Al-Thani, Mohammad Asim, Ahmed Hussein, Ahmed Sadek, Ahmed Sharaf, and Amr Fares. 2017. <span>“Characteristics, Management, and Outcomes of Surgically Treated Arteriovenous Fistula Aneurysm in Patients on Regular Hemodialysis.”</span> <em>Annals of Vascular Surgery</em> 41 (May): 46–55. <a href="https://doi.org/10.1016/j.avsg.2016.08.046">https://doi.org/10.1016/j.avsg.2016.08.046</a>.
</div>
<div id="ref-anaya-ayala2011" class="csl-entry" role="doc-biblioentry">
Anaya-Ayala, Javier E., Christopher J. Smolock, Benjamin D. Colvard, Joseph J. Naoum, Jean Bismuth, Alan B. Lumsden, Mark G. Davies, and Eric K. Peden. 2011. <span>“Efficacy of Covered Stent Placement for Central Venous Occlusive Disease in Hemodialysis Patients.”</span> <em>Journal of Vascular Surgery</em> 54 (3): 754–59. <a href="https://doi.org/10.1016/j.jvs.2011.03.260">https://doi.org/10.1016/j.jvs.2011.03.260</a>.
</div>
<div id="ref-ansari2011" class="csl-entry" role="doc-biblioentry">
Ansari, Naheed. 2011. <span>“Peritoneal Dialysis in Renal Replacement Therapy for Patients with Acute Kidney Injury.”</span> <em>International Journal of Nephrology</em> 2011 (June): 739794. <a href="https://doi.org/10.4061/2011/739794">https://doi.org/10.4061/2011/739794</a>.
</div>
<div id="ref-antoniou2009" class="csl-entry" role="doc-biblioentry">
Antoniou, G. A., M. K. Lazarides, G. S. Georgiadis, G. S. Sfyroeras, E. S. Nikolopoulos, and A. D. Giannoukas. 2009. <span>“Lower-Extremity Arteriovenous Access for Haemodialysis: A Systematic Review.”</span> <em>European Journal of Vascular and Endovascular Surgery</em> 38 (3): 365–72. <a href="https://doi.org/10.1016/j.ejvs.2009.06.003">https://doi.org/10.1016/j.ejvs.2009.06.003</a>.
</div>
<div id="ref-berman2001" class="csl-entry" role="doc-biblioentry">
Berman, Scott S., and Andrew T. Gentile. 2001. <span>“Impact of Secondary Procedures in Autogenous Arteriovenous Fistula Maturation and Maintenance.”</span> <em>Journal of Vascular Surgery</em> 34 (5): 866–71. <a href="https://doi.org/10.1067/mva.2001.118086">https://doi.org/10.1067/mva.2001.118086</a>.
</div>
<div id="ref-bountouris2018" class="csl-entry" role="doc-biblioentry">
Bountouris, Ioannis, Georgia Kritikou, Nikolaos Degermetzoglou, and Konstantinos Ioannis Avgerinos. 2018. <span>“A Review of Percutaneous Transluminal Angioplasty in Hemodialysis Fistula.”</span> <em>International Journal of Vascular Medicine</em> 2018 (March): 1420136. <a href="https://doi.org/10.1155/2018/1420136">https://doi.org/10.1155/2018/1420136</a>.
</div>
<div id="ref-bourquelot2012" class="csl-entry" role="doc-biblioentry">
Bourquelot, Pierre, Marek Rawa, Olivier Van Laere, and Gilbert Franco. 2012. <span>“Long-Term Results of Femoral Vein Transposition for Autogenous Arteriovenous Hemodialysis Access.”</span> <em>Journal of Vascular Surgery</em> 56 (2): 440–45. <a href="https://doi.org/10.1016/j.jvs.2012.01.068">https://doi.org/10.1016/j.jvs.2012.01.068</a>.
</div>
<div id="ref-brownie2016" class="csl-entry" role="doc-biblioentry">
Brownie, Evan R. 2016. <span>“A Comparison of Patency and Interventions in Thigh Versus Hemodialysis Reliable Outflow Grafts for Chronic Hemodialysis Vascular Access.”</span> <em>JOURNAL OF VASCULAR SURGERY</em> 64 (5): 8.
</div>
<div id="ref-caromonroig2018" class="csl-entry" role="doc-biblioentry">
Caro Monroig, Angeliz, Shilpa N. Reddy, Jeffrey Forris Beecham Chick, Therese E. Sammarco, Jesse L. Chittams, and Scott O. Trerotola. 2018. <span>“Fistulography of a Patent Hemodialysis Access: When Not to Treat and Implications for Establishing a Nontreatment Rate.”</span> <em>Journal of Vascular and Interventional Radiology: JVIR</em> 29 (3): 376–82. <a href="https://doi.org/10.1016/j.jvir.2017.11.012">https://doi.org/10.1016/j.jvir.2017.11.012</a>.
</div>
<div id="ref-degiovanni2020" class="csl-entry" role="doc-biblioentry">
DeGiovanni, Jason, Andrew Son, and Payam Salehi. 2020. <span>“Transposition of External Jugular to Proximal Internal Jugular Vein for Relief of Venous Thoracic Outlet Syndrome and Maintenance of Arteriovenous Fistula Access for Chronic Hemodialysis: A New Approach.”</span> <em>The Journal of Vascular Access</em> 21 (1): 98–102. <a href="https://doi.org/10.1177/1129729819851063">https://doi.org/10.1177/1129729819851063</a>.
</div>
<div id="ref-nationalkidneyfoundation2015" class="csl-entry" role="doc-biblioentry">
Foundation, National Kidney. 2015. <span>“KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update.”</span> <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em> 66 (5): 884–930. <a href="https://doi.org/10.1053/j.ajkd.2015.07.015">https://doi.org/10.1053/j.ajkd.2015.07.015</a>.
</div>
<div id="ref-galbusera2009" class="csl-entry" role="doc-biblioentry">
Galbusera, Miriam, Giuseppe Remuzzi, and Paola Boccardo. 2009. <span>“Treatment of Bleeding in Dialysis Patients.”</span> <em>Seminars in Dialysis</em> 22 (3): 279–86. <a href="https://doi.org/10.1111/j.1525-139X.2008.00556.x">https://doi.org/10.1111/j.1525-139X.2008.00556.x</a>.
</div>
<div id="ref-gilmore2006" class="csl-entry" role="doc-biblioentry">
Gilmore, JoAnne. 2006. <span>“KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations–2006 Updates.”</span> <em>Nephrology Nursing Journal: Journal of the American Nephrology Nurses’ Association</em> 33 (5): 487–88.
</div>
<div id="ref-glickman2011" class="csl-entry" role="doc-biblioentry">
Glickman, Marc H. 2011. <span>“HeRO Vascular Access Device.”</span> <em>Seminars in Vascular Surgery</em> 24 (2): 108–12. <a href="https://doi.org/10.1053/j.semvascsurg.2011.05.006">https://doi.org/10.1053/j.semvascsurg.2011.05.006</a>.
</div>
<div id="ref-glickman2015" class="csl-entry" role="doc-biblioentry">
Glickman, Marc H., Jason Burgess, David Cull, Prabir Roy-Chaudhury, and Harry Schanzer. 2015. <span>“Prospective Multicenter Study with a 1-Year Analysis of a New Vascular Graft Used for Early Cannulation in Patients Undergoing Hemodialysis.”</span> <em>Journal of Vascular Surgery</em> 62 (2): 434–41. <a href="https://doi.org/10.1016/j.jvs.2015.03.020">https://doi.org/10.1016/j.jvs.2015.03.020</a>.
</div>
<div id="ref-gradman2005" class="csl-entry" role="doc-biblioentry">
Gradman, Wayne S., Judith Laub, and William Cohen. 2005. <span>“Femoral Vein Transposition for Arteriovenous Hemodialysis Access: Improved Patient Selection and Intraoperative Measures Reduce Postoperative Ischemia.”</span> <em>Journal of Vascular Surgery</em> 41 (2): 279–84. <a href="https://doi.org/10.1016/j.jvs.2004.10.039">https://doi.org/10.1016/j.jvs.2004.10.039</a>.
</div>
<div id="ref-vascularaccess2006workgroup2006" class="csl-entry" role="doc-biblioentry">
Group, Vascular Access 2006 Work. 2006. <span>“Clinical Practice Guidelines for Vascular Access.”</span> <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em> 48 Suppl 1 (July): S176–247. <a href="https://doi.org/10.1053/j.ajkd.2006.04.029">https://doi.org/10.1053/j.ajkd.2006.04.029</a>.
</div>
<div id="ref-gupta2011" class="csl-entry" role="doc-biblioentry">
Gupta, NavYash, Theodore H. Yuo, Gerhardt Konig, Ellen Dillavou, Steven A. Leers, Rabih A. Chaer, Jae S. Cho, and Michel S. Makaroun. 2011. <span>“Treatment Strategies of Arterial Steal After Arteriovenous Access.”</span> <em>Journal of Vascular Surgery</em> 54 (1): 162–67. <a href="https://doi.org/10.1016/j.jvs.2010.10.134">https://doi.org/10.1016/j.jvs.2010.10.134</a>.
</div>
<div id="ref-han2017" class="csl-entry" role="doc-biblioentry">
Han, Sun, Pil Won Seo, and Jae-Wook Ryu. 2017. <span>“Surgical Outcomes of Forearm Loop Arteriovenous Fistula Formation Using Tapered Versus Non-Tapered Polytetrafluoroethylene Grafts.”</span> <em>The Korean Journal of Thoracic and Cardiovascular Surgery</em> 50 (1): 30–35. <a href="https://doi.org/10.5090/kjtcs.2017.50.1.30">https://doi.org/10.5090/kjtcs.2017.50.1.30</a>.
</div>
<div id="ref-huber2004" class="csl-entry" role="doc-biblioentry">
Huber, Thomas S., Christa M. Hirneise, W.Anthony Lee, Timothy C. Flynn, and James M. Seeger. 2004. <span>“Outcome After Autogenous Brachial-Axillary Translocated Superficial Femoropopliteal Vein Hemodialysis Access.”</span> <em>Journal of Vascular Surgery</em> 40 (2): 311–18. <a href="https://doi.org/10.1016/j.jvs.2004.04.018">https://doi.org/10.1016/j.jvs.2004.04.018</a>.
</div>
<div id="ref-huber2002" class="csl-entry" role="doc-biblioentry">
Huber, Thomas S., C. Keith Ozaki, Timothy C. Flynn, W. Anthony Lee, Scott A. Berceli, Christa M. Hirneise, Lori M. Carlton, Jeffrey W. Carter, Edward A. Ross, and James M. Seeger. 2002. <span>“Prospective Validation of an Algorithm to Maximize Native Arteriovenous Fistulae for Chronic Hemodialysis Access.”</span> <em>Journal of Vascular Surgery</em> 36 (3): 452–59. <a href="https://doi.org/10.1067/mva.2002.127342">https://doi.org/10.1067/mva.2002.127342</a>.
</div>
<div id="ref-junyanwee2018" class="csl-entry" role="doc-biblioentry">
Jun Yan Wee, Ian, Ismail Heyder Mohamed, Amit Patel, and Andrew M. T. L. Choong. 2018. <span>“A Systematic Review and Meta-Analysis of One-Stage Versus Two-Stage Brachiobasilic Arteriovenous Fistula Creation.”</span> <em>Journal of Vascular Surgery</em> 68 (1): 285–97. <a href="https://doi.org/10.1016/j.jvs.2018.03.428">https://doi.org/10.1016/j.jvs.2018.03.428</a>.
</div>
<div id="ref-lazarides2018" class="csl-entry" role="doc-biblioentry">
Lazarides, Miltos K., Christos Argyriou, Andreas Koutsoumpelis, Efstratios I. Georgakarakos, and George S. Georgiadis. 2018. <span>“Thigh Arteriovenous Grafts. Quantitative Comparison with Alternative Options: A Meta-Analysis.”</span> <em>The Journal of Vascular Access</em> 19 (5): 430–35. <a href="https://doi.org/10.1177/1129729818762991">https://doi.org/10.1177/1129729818762991</a>.
</div>
<div id="ref-leake2015" class="csl-entry" role="doc-biblioentry">
Leake, Andrew E., Daniel G. Winger, Steven A. Leers, Navyash Gupta, and Ellen D. Dillavou. 2015. <span>“Management and Outcomes of Dialysis Access-Associated Steal Syndrome.”</span> <em>Journal of Vascular Surgery</em> 61 (3): 754–61. <a href="https://doi.org/10.1016/j.jvs.2014.10.038">https://doi.org/10.1016/j.jvs.2014.10.038</a>.
</div>
<div id="ref-li2017" class="csl-entry" role="doc-biblioentry">
Li, Shuo, Brian N. King, Noel Velasco, Yogesh Kumar, and Nishant Gupta. 2017. <span>“Cystic Adventitial Disease—Case Series and Review of Literature.”</span> <em>Annals of Translational Medicine</em> 5 (16): 327. <a href="https://doi.org/10.21037/atm.2017.05.04">https://doi.org/10.21037/atm.2017.05.04</a>.
</div>
<div id="ref-lok2017" class="csl-entry" role="doc-biblioentry">
Lok, Charmaine E., Dheeraj K. Rajan, Jason Clement, Mercedeh Kiaii, Ravi Sidhu, Ken Thomson, George Buldo, et al. 2017. <span>“Endovascular Proximal Forearm Arteriovenous Fistula for Hemodialysis Access: Results of the Prospective, Multicenter Novel Endovascular Access Trial (NEAT).”</span> <em>American Journal of Kidney Diseases</em> 70 (4): 486–97. <a href="https://doi.org/10.1053/j.ajkd.2017.03.026">https://doi.org/10.1053/j.ajkd.2017.03.026</a>.
</div>
<div id="ref-macsata2019" class="csl-entry" role="doc-biblioentry">
Macsata, Robyn A, and Anton N Sidawy. 2019. <span>“175: Hemodialysis Access: General Considerations and Strategies to Optimize Access Placement.”</span> In <em>Rutherford’s Vascular Surgery and Endovascular Therapy</em>. Elsevier Inc.
</div>
<div id="ref-meritmedical" class="csl-entry" role="doc-biblioentry">
Medical, Merit. n.d. <span>“HeRO Graft Instructions for Use.”</span> <a href="https://cloud.merit.com/catalog/IFUs/403225012MLP.pdf">https://cloud.merit.com/catalog/IFUs/403225012MLP.pdf</a>.
</div>
<div id="ref-nguyen2007" class="csl-entry" role="doc-biblioentry">
Nguyen, T. H., T. D. Bui, I. L. Gordon, and S. E. Wilson. 2007. <span>“Functional Patency of Autogenous AV Fistulas for Hemodialysis.”</span> <em>The Journal of Vascular Access</em> 8 (4): 275–80.
</div>
<div id="ref-padberg2008" class="csl-entry" role="doc-biblioentry">
Padberg, Frank T., Keith D. Calligaro, and Anton N. Sidawy. 2008. <span>“Complications of Arteriovenous Hemodialysis Access: Recognition and Management.”</span> <em>Journal of Vascular Surgery</em> 48 (5): S55–80. <a href="https://doi.org/10.1016/j.jvs.2008.08.067">https://doi.org/10.1016/j.jvs.2008.08.067</a>.
</div>
<div id="ref-parekh2016" class="csl-entry" role="doc-biblioentry">
Parekh, Vishal B., Vandana D. Niyyar, and Tushar J. Vachharajani. 2016. <span>“Lower Extremity Permanent Dialysis Vascular Access.”</span> <em>Clinical Journal of the American Society of Nephrology</em> 11 (9): 1693–1702. <a href="https://doi.org/10.2215/CJN.01780216">https://doi.org/10.2215/CJN.01780216</a>.
</div>
<div id="ref-pasklinsky2011" class="csl-entry" role="doc-biblioentry">
Pasklinsky, Garri, Robert J. Meisner, Nicos Labropoulos, Luis Leon, Antonios P. Gasparis, David Landau, Apostolos K. Tassiopoulos, and Peter J. Pappas. 2011. <span>“Management of True Aneurysms of Hemodialysis Access Fistulas.”</span> <em>Journal of Vascular Surgery</em> 53 (5): 1291–97. <a href="https://doi.org/10.1016/j.jvs.2010.11.100">https://doi.org/10.1016/j.jvs.2010.11.100</a>.
</div>
<div id="ref-paulson2002" class="csl-entry" role="doc-biblioentry">
Paulson, William D., Sunanda J. Ram, and Gazi B. Zibari. 2002. <span>“Vascular Access: Anatomy, Examination, Management.”</span> <em>Seminars in Nephrology</em> 22 (3): 183–94. <a href="https://doi.org/10.1053/snep.2002.31702">https://doi.org/10.1053/snep.2002.31702</a>.
</div>
<div id="ref-pike2019" class="csl-entry" role="doc-biblioentry">
Pike, Steven L., Alik Farber, Nkiruka Arinze, Scott Levin, Thomas W. Cheng, Douglas W. Jones, Tze-Woei Tan, Mahmoud Malas, Denis Rybin, and Jeffrey J. Siracuse. 2019. <span>“Patients with Lower Extremity Dialysis Access Have Poor Primary Patency and Survival.”</span> <em>Journal of Vascular Surgery</em> 70 (6): 1913–18. <a href="https://doi.org/10.1016/j.jvs.2019.03.037">https://doi.org/10.1016/j.jvs.2019.03.037</a>.
</div>
<div id="ref-roberts2019" class="csl-entry" role="doc-biblioentry">
Roberts, Lauren, Alik Farber, Douglas W. Jones, Karen Woo, Mohammad H. Eslami, Jessica Simons, Mahmoud Malas, Tze-Woei Tan, Denis Rybin, and Jeffrey J. Siracuse. 2019. <span>“Tapered Arteriovenous Grafts Do Not Provide Significant Advantage over Nontapered Grafts in Upper Extremity Dialysis Access.”</span> <em>Journal of Vascular Surgery</em> 69 (5): 1552–58. <a href="https://doi.org/10.1016/j.jvs.2018.08.181">https://doi.org/10.1016/j.jvs.2018.08.181</a>.
</div>
<div id="ref-schanzer2004" class="csl-entry" role="doc-biblioentry">
Schanzer, Harry, and David Eisenberg. 2004. <span>“Management of Steal Syndrome Resulting from Dialysis Access.”</span> <em>Seminars in Vascular Surgery</em> 17 (1): 45–49. <a href="https://doi.org/10.1053/j.semvascsurg.2003.11.003">https://doi.org/10.1053/j.semvascsurg.2003.11.003</a>.
</div>
<div id="ref-sgroi2019" class="csl-entry" role="doc-biblioentry">
Sgroi, Michael D., Graeme McFarland, Nathan K. Itoga, Ehab Sorial, and Manuel Garcia-Toca. 2019. <span>“Arteriovenous Fistula and Graft Construction in Patients with Implantable Cardiac Devices: Does Side Matter?”</span> <em>Annals of Vascular Surgery</em> 54 (January): 66–71. <a href="https://doi.org/10.1016/j.avsg.2018.10.003">https://doi.org/10.1016/j.avsg.2018.10.003</a>.
</div>
<div id="ref-shemesh2008" class="csl-entry" role="doc-biblioentry">
Shemesh, David, Ilya Goldin, Ibrahim Zaghal, Daniel Berlowitz, David Raveh, and Oded Olsha. 2008. <span>“Angioplasty with Stent Graft Versus Bare Stent for Recurrent Cephalic Arch Stenosis in Autogenous Arteriovenous Access for Hemodialysis: A Prospective Randomized Clinical Trial.”</span> <em>Journal of Vascular Surgery</em> 48 (6): 1524–1531.e2. <a href="https://doi.org/10.1016/j.jvs.2008.07.071">https://doi.org/10.1016/j.jvs.2008.07.071</a>.
</div>
<div id="ref-sidawy2008" class="csl-entry" role="doc-biblioentry">
Sidawy, Anton N., Lawrence M. Spergel, Anatole Besarab, Michael Allon, William C. Jennings, Frank T. Padberg, M. Hassan Murad, et al. 2008. <span>“The Society for Vascular Surgery: Clinical Practice Guidelines for the Surgical Placement and Maintenance of Arteriovenous Hemodialysis Access.”</span> <em>Journal of Vascular Surgery</em> 48 (5): S2–25. <a href="https://doi.org/10.1016/j.jvs.2008.08.042">https://doi.org/10.1016/j.jvs.2008.08.042</a>.
</div>
<div id="ref-sinnakirouchenan2011" class="csl-entry" role="doc-biblioentry">
Sinnakirouchenan, Ramapriya, and Jean L. Holley. 2011. <span>“Peritoneal Dialysis Versus Hemodialysis: Risks, Benefits, and Access Issues.”</span> <em>Advances in Chronic Kidney Disease</em> 18 (6): 428–32. <a href="https://doi.org/10.1053/j.ackd.2011.09.001">https://doi.org/10.1053/j.ackd.2011.09.001</a>.
</div>
<div id="ref-siracuse2019" class="csl-entry" role="doc-biblioentry">
Siracuse, Jeffrey J., Thomas W. Cheng, Nkiruka V. Arinze, Scott R. Levin, Douglas W. Jones, Mahmoud B. Malas, Jeffrey A. Kalish, Denis Rybin, and Alik Farber. 2019. <span>“Snuffbox Arteriovenous Fistulas Have Similar Outcomes and Patency as Wrist Arteriovenous Fistulas.”</span> <em>Journal of Vascular Surgery</em> 70 (2): 554–61. <a href="https://doi.org/10.1016/j.jvs.2018.11.030">https://doi.org/10.1016/j.jvs.2018.11.030</a>.
</div>
<div id="ref-siracuse2014" class="csl-entry" role="doc-biblioentry">
Siracuse, Jeffrey J., Heather L. Gill, Inkyong Parrack, Zhen S. Huang, Darren B. Schneider, Peter H. Connolly, and Andrew J. Meltzer. 2014. <span>“Variability in Anesthetic Considerations for Arteriovenous Fistula Creation.”</span> <em>The Journal of Vascular Access</em> 15 (5): 364–69. <a href="https://doi.org/10.5301/jva.5000215">https://doi.org/10.5301/jva.5000215</a>.
</div>
<div id="ref-smith2012" class="csl-entry" role="doc-biblioentry">
Smith, George E., Risha Gohil, and Ian C. Chetter. 2012. <span>“Factors Affecting the Patency of Arteriovenous Fistulas for Dialysis Access.”</span> <em>Journal of Vascular Surgery</em> 55 (3): 849–55. <a href="https://doi.org/10.1016/j.jvs.2011.07.095">https://doi.org/10.1016/j.jvs.2011.07.095</a>.
</div>
<div id="ref-talebi2011" class="csl-entry" role="doc-biblioentry">
Talebi, Mahnaz, Behzad Salari, Hossein Ghannadan, Farzad Kakaei, and Sima Abedi Azar. 2011. <span>“Nerve Conduction Changes Following Arteriovenous Fistula Construction in Hemodialysis Patients.”</span> <em>International Urology and Nephrology</em> 43 (3): 849–53. <a href="https://doi.org/10.1007/s11255-010-9740-9">https://doi.org/10.1007/s11255-010-9740-9</a>.
</div>
<div id="ref-vahdatpour2012" class="csl-entry" role="doc-biblioentry">
Vahdatpour, Babak, Razieh Maghroori, Mojgan Mortazavi, and Saeid Khosrawi. 2012. <span>“Evaluation of Ulnar Neuropathy on Hemodialysis Patients.”</span> <em>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</em> 17 (10): 905–10. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698646/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698646/</a>.
</div>
<div id="ref-yevzlin2016" class="csl-entry" role="doc-biblioentry">
Yevzlin, Alexander S., Micah R. Chan, and Arif Asif. 2016. <span>“Hand Ischemia in a Patient with an Arteriovenous Fistula.”</span> <em>American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation</em> 67 (3): 512–15. <a href="https://doi.org/10.1053/j.ajkd.2015.07.041">https://doi.org/10.1053/j.ajkd.2015.07.041</a>.
</div>
<div id="ref-zanow2006" class="csl-entry" role="doc-biblioentry">
Zanow, Jurgen, Ulf Kruger, and Hans Scholz. 2006. <span>“Proximalization of the Arterial Inflow: A New Technique to Treat Access-Related Ischemia.”</span> <em>Journal of Vascular Surgery</em> 43 (6): 1216–21. <a href="https://doi.org/10.1016/j.jvs.2006.01.025">https://doi.org/10.1016/j.jvs.2006.01.025</a>.
</div>
</div>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      let href = ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./upper-extremity.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Upper Extremity</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./thoracic-aorta.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Thoracic Aorta</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>